(3S,9S,12R,18S,21S,23R)-12-(aminomethyl)-3-tert-butyl-23-hydroxy-18-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2,5,11,14,17,20-hexaoxo-7-thia-1,4,10,13,16,19-hexazabicyclo[19.3.0]tetracosane-9-carboxamide

C33H45N9O8S2 — CID 166916762

IUPAC(3S,9S,12R,18S,21S,23R)-12-(aminomethyl)-3-tert-butyl-23-hydroxy-18-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2,5,11,14,17,20-hexaoxo-7-thia-1,4,10,13,16,19-hexazabicyclo[19.3.0]tetracosane-9-carboxamide
SMILESCc1ncsc1-c1ccc([C@@H]2NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](C(C)(C)C)NC(=O)CSC[C@H](C(N)=O)NC(=O)[C@@H](CN)NC(=O)CNC2=O)cc1
InChIInChI=1S/C33H45N9O8S2/c1-16-26(52-15-37-16)18-7-5-17(6-8-18)25-31(49)36-11-23(44)38-20(10-34)29(47)39-21(28(35)46)13-51-14-24(45)40-27(33(2,3)4)32(50)42-12-19(43)9-22(42)30(48)41-25/h5-8,15,19-22,25,27,43H,9-14,34H2,1-4H3,(H2,35,46)(H,36,49)(H,38,44)(H,39,47)(H,40,45)(H,41,48)/t19-,20-,21-,22+,25+,27-/m1/s1
InChIKeyLSHIICVXCCONCF-WWDRKBGDSA-N
MW759.91 g/mol
LogP-1.95
Rot. Bonds4

About (3S,9S,12R,18S,21S,23R)-12-(aminomethyl)-3-tert-butyl-23-hydroxy-18-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2,5,11,14,17,20-hexaoxo-7-thia-1,4,10,13,16,19-hexazabicyclo[19.3.0]tetracosane-9-carboxamide

(3S,9S,12R,18S,21S,23R)-12-(aminomethyl)-3-tert-butyl-23-hydroxy-18-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2,5,11,14,17,20-hexaoxo-7-thia-1,4,10,13,16,19-hexazabicyclo[19.3.0]tetracosane-9-carboxamide (PubChem CID 166916762) has the molecular formula C33H45N9O8S2 and a molecular weight of 759.91 g/mol. Its IUPAC name is (3S,9S,12R,18S,21S,23R)-12-(aminomethyl)-3-tert-butyl-23-hydroxy-18-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2,5,11,14,17,20-hexaoxo-7-thia-1,4,10,13,16,19-hexazabicyclo[19.3.0]tetracosane-9-carboxamide.

Molecular Properties

Compound Name(3S,9S,12R,18S,21S,23R)-12-(aminomethyl)-3-tert-butyl-23-hydroxy-18-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2,5,11,14,17,20-hexaoxo-7-thia-1,4,10,13,16,19-hexazabicyclo[19.3.0]tetracosane-9-carboxamide
PubChem CID166916762
Molecular FormulaC33H45N9O8S2
Molecular Weight759.91 g/mol
Exact Mass759.28
IUPAC Name(3S,9S,12R,18S,21S,23R)-12-(aminomethyl)-3-tert-butyl-23-hydroxy-18-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2,5,11,14,17,20-hexaoxo-7-thia-1,4,10,13,16,19-hexazabicyclo[19.3.0]tetracosane-9-carboxamide
SMILESCc1ncsc1-c1ccc([C@@H]2NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](C(C)(C)C)NC(=O)CSC[C@H](C(N)=O)NC(=O)[C@@H](CN)NC(=O)CNC2=O)cc1
InChIInChI=1S/C33H45N9O8S2/c1-16-26(52-15-37-16)18-7-5-17(6-8-18)25-31(49)36-11-23(44)38-20(10-34)29(47)39-21(28(35)46)13-51-14-24(45)40-27(33(2,3)4)32(50)42-12-19(43)9-22(42)30(48)41-25/h5-8,15,19-22,25,27,43H,9-14,34H2,1-4H3,(H2,35,46)(H,36,49)(H,38,44)(H,39,47)(H,40,45)(H,41,48)/t19-,20-,21-,22+,25+,27-/m1/s1
InChIKeyLSHIICVXCCONCF-WWDRKBGDSA-N
XLogP-1.95
TPSA268.04 Ų
H-Bond Donors8
H-Bond Acceptors12
Rotatable Bonds4
Heavy Atoms52
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500759.91
LogP ≤ 5-1.95
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1012

Analyze (3S,9S,12R,18S,21S,23R)-12-(aminomethyl)-3-tert-butyl-23-hydroxy-18-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2,5,11,14,17,20-hexaoxo-7-thia-1,4,10,13,16,19-hexazabicyclo[19.3.0]tetracosane-9-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,9S,12R,18S,21S,23R)-12-(aminomethyl)-3-tert-butyl-23-hydroxy-18-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2,5,11,14,17,20-hexaoxo-7-thia-1,4,10,13,16,19-hexazabicyclo[19.3.0]tetracosane-9-carboxamide?
The IUPAC name of (3S,9S,12R,18S,21S,23R)-12-(aminomethyl)-3-tert-butyl-23-hydroxy-18-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2,5,11,14,17,20-hexaoxo-7-thia-1,4,10,13,16,19-hexazabicyclo[19.3.0]tetracosane-9-carboxamide (CID 166916762) is (3S,9S,12R,18S,21S,23R)-12-(aminomethyl)-3-tert-butyl-23-hydroxy-18-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2,5,11,14,17,20-hexaoxo-7-thia-1,4,10,13,16,19-hexazabicyclo[19.3.0]tetracosane-9-carboxamide.
What is the SMILES notation for (3S,9S,12R,18S,21S,23R)-12-(aminomethyl)-3-tert-butyl-23-hydroxy-18-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2,5,11,14,17,20-hexaoxo-7-thia-1,4,10,13,16,19-hexazabicyclo[19.3.0]tetracosane-9-carboxamide?
The canonical SMILES for (3S,9S,12R,18S,21S,23R)-12-(aminomethyl)-3-tert-butyl-23-hydroxy-18-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2,5,11,14,17,20-hexaoxo-7-thia-1,4,10,13,16,19-hexazabicyclo[19.3.0]tetracosane-9-carboxamide is Cc1ncsc1-c1ccc([C@@H]2NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@H](C(C)(C)C)NC(=O)CSC[C@H](C(N)=O)NC(=O)[C@@H](CN)NC(=O)CNC2=O)cc1.
What is the InChIKey of (3S,9S,12R,18S,21S,23R)-12-(aminomethyl)-3-tert-butyl-23-hydroxy-18-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2,5,11,14,17,20-hexaoxo-7-thia-1,4,10,13,16,19-hexazabicyclo[19.3.0]tetracosane-9-carboxamide?
The InChIKey is LSHIICVXCCONCF-WWDRKBGDSA-N. The full InChI is InChI=1S/C33H45N9O8S2/c1-16-26(52-15-37-16)18-7-5-17(6-8-18)25-31(49)36-11-23(44)38-20(10-34)29(47)39-21(28(35)46)13-51-14-24(45)40-27(33(2,3)4)32(50)42-12-19(43)9-22(42)30(48)41-25/h5-8,15,19-22,25,27,43H,9-14,34H2,1-4H3,(H2,35,46)(H,36,49)(H,38,44)(H,39,47)(H,40,45)(H,41,48)/t19-,20-,21-,22+,25+,27-/m1/s1.
What are the key properties of (3S,9S,12R,18S,21S,23R)-12-(aminomethyl)-3-tert-butyl-23-hydroxy-18-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2,5,11,14,17,20-hexaoxo-7-thia-1,4,10,13,16,19-hexazabicyclo[19.3.0]tetracosane-9-carboxamide?
(3S,9S,12R,18S,21S,23R)-12-(aminomethyl)-3-tert-butyl-23-hydroxy-18-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2,5,11,14,17,20-hexaoxo-7-thia-1,4,10,13,16,19-hexazabicyclo[19.3.0]tetracosane-9-carboxamide has a molecular weight of 759.91 g/mol, XLogP of -1.95, 4 rotatable bonds, 8 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,9S,12R,18S,21S,23R)-12-(aminomethyl)-3-tert-butyl-23-hydroxy-18-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2,5,11,14,17,20-hexaoxo-7-thia-1,4,10,13,16,19-hexazabicyclo[19.3.0]tetracosane-9-carboxamide is sourced from PubChem (CID 166916762), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).